GO:0004782 sulfinoalanine decarboxylase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004782 (sulfinoalanine decarboxylase activity) catalyzes the pyridoxal 5'-phosphate-dependent decarboxylation of 3-sulfino-L-alanine (cysteine sulfinic acid) to hypotaurine and CO2, a committed step in taurine biosynthesis.
• The enzyme is widely known as cysteine sulfinic acid decarboxylase (CSAD) and is encoded by the CSAD gene in mammals; its activity is the rate-limiting determinant of taurine production in liver and brain.
• Hepatic CSAD activity is nutritionally and hormonally regulated, responding to dietary protein/casein levels and thyroid hormone status in rodent models.
• Taurine, the downstream product, is conditionally essential in cats and is implicated in retinal, cardiac, and neurological function, making CSAD a physiologically significant node.
• CSAD has emerged as an immune regulator: it inhibits excessive inflammation during viral infections through the NF-kappaB signaling pathway.
• Comparative and genomic studies show that PLP_deC gene family members, including CSAD orthologs, drive taurine synthesis across diverse taxa such as bivalves.
Description
Sulfinoalanine decarboxylase activity (GO:0004782) is a molecular function defined as the catalysis of the reaction 3-sulfino-L-alanine = hypotaurine + CO2. This activity, historically termed cysteine sulfinic acid decarboxylase (CSAD) or cysteinesulfinate decarboxylase, is a pyridoxal 5'-phosphate (PLP)-dependent decarboxylation that commits sulfur amino acid metabolites to the taurine biosynthetic pathway. Because taurine serves diverse roles in osmoregulation, bile acid conjugation, retinal function, and cardiac excitability, the enzyme that gates its production is of broad physiological interest. The reaction is central to sulfur amino acid metabolism. Cysteine is oxidized to cysteine sulfinic acid (3-sulfino-L-alanine), which can either be decarboxylated by CSAD to hypotaurine or transaminated; the CSAD route is the principal source of hypotaurine, which is then oxidized to taurine. Consequently, changes in CSAD expression or activity directly alter taurine availability in tissues such as liver and brain. For researchers, GO:0004782 provides a precise functional annotation for genes and proteins capable of this decarboxylation. It is used in genome annotation, comparative genomics of the PLP_deC family, and functional studies of taurine biology. Recent work has also linked CSAD to immune signaling, expanding its relevance beyond classical amino acid metabolism.
sulfinoalanine decarboxylase activity At A Glance
| GO ID | GO:0004782 |
|---|---|
| GO term | sulfinoalanine decarboxylase activity |
| Ontology | molecular_function |
| Synonym | cysteine-sulfinate decarboxylase activity; cysteinesulfinate decarboxylase activity; CSAD; 3-sulfino-L-alanine carboxy-lyase activity |
| Major function | Catalyzes decarboxylation of 3-sulfino-L-alanine to hypotaurine and CO2 |
| Cofactor | Pyridoxal 5'-phosphate (PLP) dependent |
| Pathway context | Taurine biosynthesis from cysteine |
| Representative gene | CSAD (mammals); PLP_deC family members in invertebrates |
| Tissue relevance | Liver and brain are major sites of activity |
What Is GO:0004782?
In our own words, GO:0004782 describes the enzymatic capability to remove the carboxyl group from 3-sulfino-L-alanine (also called cysteine sulfinic acid), releasing carbon dioxide and producing hypotaurine. This is a decarboxylation reaction and, in the characterized enzymes, depends on the cofactor pyridoxal 5'-phosphate. The activity is synonymous with cysteine sulfinic acid decarboxylase (CSAD) and represents the committed step in the taurine biosynthesis pathway from cysteine.
Why Is sulfinoalanine decarboxylase activity Important in Cell Biology?
GO:0004782 is important because it defines the enzymatic step that controls taurine production from cysteine. Taurine is a conditionally essential nutrient with roles in bile acid conjugation, osmoregulation, retinal and cardiac function, and neurodevelopment, and its deficiency in cats causes retinal degeneration and other pathologies. Because CSAD activity determines how much hypotaurine, and ultimately taurine, is made, the enzyme is a key metabolic control point. Beyond metabolism, CSAD has been identified as an inhibitor of excessive inflammation during viral infections via the NF-kappaB pathway, linking this molecular function to immune regulation. Understanding GO:0004782 therefore spans nutrition, physiology, immunology, and comparative genomics.
• Defines the committed step in taurine biosynthesis from cysteine.
• Determines tissue taurine levels, which are critical for retinal and cardiac function.
• Is nutritionally regulated: hepatic CSAD activity changes with dietary casein/protein intake.
• Is hormonally regulated: thyroid hormone administration alters CSAD activity in rats.
• Shows species-, age-, and sex-related differences in liver and brain.
• Provides a functional annotation for PLP_deC gene family members across taxa.
• Links sulfur amino acid metabolism to immune signaling through NF-kappaB.
• Serves as a biomarker or target in studies of taurine-related disorders.
• Enables comparative genomics of taurine synthesis capacity in animals.
• Supports metabolic engineering and nutritional studies of sulfur amino acids.
What Happens During sulfinoalanine decarboxylase activity?
Substrate generation: cysteine to 3-sulfino-L-alanine
In simple terms: First, the amino acid cysteine is converted into the substrate for the enzyme.
The pathway begins with the oxidation of cysteine to cysteine sulfinic acid (3-sulfino-L-alanine), the substrate for GO:0004782. This step is part of sulfur amino acid metabolism, in which cysteine is catabolized through multiple routes including oxidation and transamination. The availability of 3-sulfino-L-alanine therefore influences flux through the CSAD reaction.
Decarboxylation of 3-sulfino-L-alanine to hypotaurine
In simple terms: The enzyme removes a carboxyl group from the substrate, releasing CO2 and forming hypotaurine.
The defining catalytic event of GO:0004782 is the decarboxylation of 3-sulfino-L-alanine to yield hypotaurine and carbon dioxide. This reaction is catalyzed by cysteine sulfinic acid decarboxylase (CSAD) and is the committed step in taurine biosynthesis. The enzyme is PLP-dependent, a common feature of amino acid decarboxylases.
Oxidation of hypotaurine to taurine
In simple terms: Hypotaurine is then converted into taurine, the final product of the pathway.
Hypotaurine produced by the CSAD reaction is subsequently oxidized to taurine. Taurine is the end product of this sulfur amino acid pathway and is conditionally essential in some species, notably cats. The conversion of hypotaurine to taurine completes the biosynthetic route that begins with cysteine.
Tissue-specific and species-specific activity
In simple terms: Different animals and different organs have different levels of this enzyme activity.
CSAD activity varies by species, age, and sex, and is particularly prominent in liver and brain. Comparative studies have measured cysteinesulfinate decarboxylase activity and taurine concentrations across animal species, revealing differences that may reflect dietary and physiological adaptations. In cats, low taurine synthesis capacity contributes to the essentiality of dietary taurine.
Key Genes Involved in GO:0004782 sulfinoalanine decarboxylase activity
The genes and proteins below are directly or functionally associated with sulfinoalanine decarboxylase activity (GO:0004782) and its pathway context.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CSAD | Encodes cysteine sulfinic acid decarboxylase, the enzyme catalyzing GO:0004782 | Central to taurine biosynthesis studies; target for KO and overexpression models |
| CSAD (rat) | Hepatic CSAD activity regulated by dietary casein | Nutritional regulation studies |
| CSAD (rat) | CSAD activity responds to thyroid hormone | Hormonal regulation studies |
| CSAD (cat) | Low activity linked to taurine essentiality | Species-specific nutrition and retinal function |
| PLP_deC family (bivalves) | PLP-dependent decarboxylases involved in taurine synthesis | Comparative genomics of taurine synthesis |
| GAD1/GAD2 (context) | PLP-dependent decarboxylases related by mechanism | Comparative enzymology of PLP decarboxylases |
| GPT/GGT (context) | Transamination routes competing for cysteine sulfinate | Pathway flux studies |
| NF-kB pathway components | Mediators of inflammation inhibited by CSAD | Immune regulation studies |
| CDO1 (context) | Cysteine dioxygenase upstream of cysteine sulfinate | Sulfur amino acid metabolism |
| CSAD orthologs (zebrafish) | Model for taurine synthesis | Developmental and metabolic studies |
| CSAD orthologs (mouse) | Model for CSAD regulation | KO and knock-in studies |
| CSAD orthologs (human) | Human CSAD enzyme | Disease association and pharmacology |
| Taurine transporter SLC6A6 (context) | Uptake of taurine | Taurine homeostasis studies |
| Cysteine dioxygenase (CDO) | Produces cysteine sulfinate | Upstream pathway analysis |
| Hypotaurine dehydrogenase (context) | Oxidizes hypotaurine to taurine | Pathway completion studies |
| PLP synthase (context) | Provides PLP cofactor | Cofactor availability studies |
How Is sulfinoalanine decarboxylase activity Regulated?
CSAD activity is regulated at multiple levels. Nutritionally, hepatic cysteine sulfinic acid decarboxylase activity in rats changes with the level of dietary casein, indicating that protein intake modulates enzyme activity. Hormonally, thyroid hormone administration alters CSAD activity in rats, linking thyroid status to taurine synthesis. There are also species-, age-, and sex-dependent differences in CSAD activity in liver and brain, suggesting developmental and endocrine influences. At the pathway level, competition between decarboxylation and transamination of cysteine sulfinic acid can affect flux through GO:0004782. In immune contexts, CSAD inhibits excessive inflammation during viral infections through the NF-kappaB signaling pathway, indicating that its expression or activity can influence inflammatory signaling.
sulfinoalanine decarboxylase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CSAD | Taurine deficiency; retinal degeneration | CSAD knockout mouse; taurine supplementation |
| CSAD | Excessive inflammation during viral infection | CSAD overexpression in cell lines; NF-kappaB reporter |
| CSAD | Cardiac dysfunction linked to low taurine | Cardiomyocyte-specific CSAD KO |
| CSAD | Neurological dysfunction | Brain-specific CSAD KO; behavioral tests |
| CSAD | Metabolic regulation of sulfur amino acids | Hepatocyte CSAD KO; dietary casein studies |
Taurine deficiency and retinal/cardiac dysfunction
Because GO:0004782 controls taurine biosynthesis, reduced CSAD activity can contribute to taurine deficiency. In cats, taurine is an essential nutrient, and deficiency causes retinal degeneration and other pathologies. Taurine is also important for cardiac function, and low taurine levels have been associated with cardiac dysfunction. Thus, impaired CSAD activity may exacerbate conditions linked to low taurine.
Inflammation and viral infection
Recent evidence shows that CSAD inhibits excessive inflammation during viral infections through the NF-kappaB signaling pathway. This positions GO:0004782 not only in metabolism but also in immune regulation, suggesting that modulating CSAD activity could influence inflammatory outcomes during infection.
Neurological and metabolic disorders
Taurine has neuroprotective and osmoregulatory roles, and its synthesis via CSAD occurs in brain as well as liver. Alterations in CSAD activity could therefore impact neurological function, although direct disease associations require further study. Metabolic conditions affecting sulfur amino acid flux may also influence taurine availability.
From sulfinoalanine decarboxylase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of CSAD reduce taurine levels? | CSAD knockout cell line or mouse |
| Does a point mutation in the active site abolish decarboxylation? | Point-mutation knock-in of CSAD catalytic residue |
| Can tagged CSAD be used to study localization? | Knock-in of epitope-tagged CSAD |
| Does CSAD overexpression suppress inflammation? | CSAD overexpression in immune cells |
| How does thyroid hormone regulate CSAD? | Thyroid hormone treatment in CSAD reporter models |
| What is the effect of dietary protein on CSAD? | Dietary casein modulation in rodent models |
How to Study the sulfinoalanine decarboxylase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Enzymatic decarboxylation assay | CSAD activity | Tissue activity profiling |
| RNA-seq | CSAD mRNA expression | Transcriptional regulation studies |
| Metabolomics | Hypotaurine and taurine levels | Pathway flux analysis |
| CRISPR knockout | Loss of CSAD function | Taurine synthesis and inflammation |
| Overexpression | Gain of CSAD function | NF-kappaB inhibition studies |
| Western blot | CSAD protein levels | Validation of expression changes |
| Comparative genomics | PLP_deC gene family | Taurine synthesis evolution |
| Reporter assays | NF-kappaB activity | Immune regulation |
Enzymatic activity assays
CSAD activity can be measured by monitoring the decarboxylation of 3-sulfino-L-alanine to hypotaurine and CO2. Classic studies used tissue homogenates and radiolabeled substrates to quantify activity in liver and brain. These assays remain the gold standard for directly assessing GO:0004782.
Gene expression analysis
RNA-seq and qPCR can quantify CSAD mRNA levels across tissues and conditions. Such approaches help link transcriptional regulation to enzyme activity, as seen in nutritional and hormonal studies. Comparative genomics of PLP_deC genes also relies on sequence and expression data.
Metabolomics and taurine measurement
Because CSAD activity determines hypotaurine and taurine levels, metabolomic profiling of these metabolites provides a functional readout. Taurine concentrations have been measured in liver and brain across species. Such methods are essential for linking genotype to metabolic phenotype.
CRISPR-based functional genomics
CRISPR knockout and knock-in models allow direct testing of CSAD function. For example, CSAD knockout cells can be used to assess taurine synthesis and inflammatory responses. These models are complemented by overexpression and tagged knock-in approaches.
How CRISPR Can Be Used to Study GO:0004782 sulfinoalanine decarboxylase activity
Knockout
CRISPR knockout of CSAD can eliminate sulfinoalanine decarboxylase activity, allowing researchers to test its role in taurine synthesis and inflammation. Such models are valuable for studying the consequences of GO:0004782 loss in liver, brain, and immune cells.
Point Mutation
Point mutations in the CSAD catalytic site can be introduced to dissect the enzymatic mechanism, particularly residues involved in PLP binding or substrate recognition. These models help confirm that the annotated activity depends on specific amino acids.
Knock-in
Knock-in of epitope-tagged CSAD allows visualization and immunoprecipitation of the endogenous enzyme, enabling studies of its localization and interaction partners. This approach preserves native regulation while adding a tag.
Overexpression
Overexpression of CSAD can boost taurine production and has been used to demonstrate inhibition of excessive inflammation via NF-kappaB. Overexpression models are useful for gain-of-function studies and for testing therapeutic potential.
How EDITGENE Supports sulfinoalanine decarboxylase activity Research
Researchers studying sulfinoalanine decarboxylase activity-related genes often need to determine whether a candidate gene is causally involved in taurine synthesis, inflammatory regulation, or metabolic disease. EDITGENE provides the CRISPR tools and services to build precisely engineered cell models for such functional studies.
Contact EDITGENE today to design your custom CRISPR model for sulfinoalanine decarboxylase activity research.
Frequently Asked Questions About sulfinoalanine decarboxylase activity
What is sulfinoalanine decarboxylase activity?
It is the enzymatic activity defined by GO:0004782 that catalyzes the decarboxylation of 3-sulfino-L-alanine to hypotaurine and CO2, a key step in taurine biosynthesis.
What gene encodes sulfinoalanine decarboxylase activity?
In mammals, the CSAD gene encodes cysteine sulfinic acid decarboxylase, the enzyme responsible for this activity.
What is the reaction catalyzed by GO:0004782?
The reaction is 3-sulfino-L-alanine = hypotaurine + CO2, a PLP-dependent decarboxylation.
Why is sulfinoalanine decarboxylase activity important?
It controls taurine production, which is critical for retinal, cardiac, and neurological function, and it also regulates inflammation during viral infections.
How is CSAD activity regulated?
CSAD activity is regulated by dietary protein intake, thyroid hormone, and species-, age-, and sex-related factors.
What diseases are linked to CSAD?
Taurine deficiency, retinal degeneration, cardiac dysfunction, and excessive inflammation during viral infection have been linked to CSAD.
What model organisms are used to study CSAD?
Rodents, cats, and bivalves are used, with comparative studies across species.
How can I measure sulfinoalanine decarboxylase activity?
Enzymatic assays measuring hypotaurine or CO2 production, often with radiolabeled substrate, are standard.
What is the cofactor for sulfinoalanine decarboxylase?
The enzyme is pyridoxal 5'-phosphate (PLP) dependent.
Can CRISPR be used to study CSAD?
Yes, CRISPR knockout, knock-in, and overexpression models are powerful tools to study CSAD function and its role in taurine synthesis and inflammation.
Conclusion
Sulfinoalanine decarboxylase activity (GO:0004782) is a well-defined molecular function that catalyzes the committed step in taurine biosynthesis. Its regulation by diet, hormones, and species-specific factors, together with its emerging role in immune signaling, makes it a compelling target for metabolic and immunological research. Understanding this activity through CRISPR models and functional assays will continue to illuminate taurine biology and its disease relevance.
References
- 1. Zhang Y et al.. 2025. CSAD inhibits excessive inflammation during viral infections through the NF-κB signaling pathway.. J Virol 99(10):e0070625 PMID: 40952115
- 2. Stipanuk MH. 1986. Metabolism of sulfur-containing amino acids.. Annu Rev Nutr 6:179-209 PMID: 3524616
- 3. Schuller-Levis GB et al.. 2003. Taurine: new implications for an old amino acid.. FEMS Microbiol Lett 226(2):195-202 PMID: 14553911
- 4. Jerkins AA et al.. 1989. Hepatic cysteine sulfinic acid decarboxylase activity in rats fed various levels of dietary casein.. J Nutr 119(11):1593-7 PMID: 2600664
- 5. Jerkins AA et al.. 1991. Cysteine sulfinic acid decarboxylase activity in response to thyroid hormone administration in rats.. Arch Biochem Biophys 286(2):428-32 PMID: 1897967
- 6. Knopf K et al.. 1978. Taurine: an essential nutrient for the cat.. J Nutr 108(5):773-8 PMID: 641594
- 7. Pang M et al.. 2025. Genome-wide identification and analysis of the PLP_deC genes involved in taurine synthesis in bivalves.. Comp Biochem Physiol Part D Genomics Proteomics 56:101641 PMID: 40997677
- 8. Worden JA et al.. 1985. A comparison by species, age and sex of cysteinesulfinate decarboxylase activity and taurine concentration in liver and brain of animals.. Comp Biochem Physiol B 82(2):233-9 PMID: 4053584
